2Amin N E, Giske C G, Jalal S, et al. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates[J]. APMIS, 2005, 113(3). 187
3Sanders C C, Sanders W E J. Type I β-lactamase of Gramnegative bacteria: interactions with β-lactam antibiotics[J]. J Infect Dis, 1986, 154 (5): 792
4Fernandez-Cuenca F, Martinez-Martinez L, Conejo M C, et al.Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii [ J ]. J Antimicrob Chemother, 2003, 51 : 565
5Ribera A, Femandez-Cuenca F, Beceiro A, et al. Antimicrobial susceptibility and mechanisms of resistance to quinolonesand betalactams in Acinetobacter genospecies [ J ] . Antimicrob Agents Chemother, 2004,48:1430
6Walsh T R, MacGowan A P, Bennett P M. Sequence analysis and enzyme kinetics of the L-sefine beta-lactamase from Stenotrophomonas maltophilia[ J ] . Antimicrob Agents Chemother,1997, 41 (7): 1460
